AbbVie
ABBV
#26
Rank
A$604.82 B
Marketcap
A$342.21
Share price
-1.15%
Change (1 day)
28.74%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$206.61 Billion

According to AbbVie's latest financial reports the company's total liabilities are A$206.61 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$211.89 B16.13%
2023-12-31A$182.46 B2.18%
2022-12-31A$178.57 B-1.25%
2021-12-31A$180.82 B1.14%
2020-12-31A$178.77 B28.66%
2019-12-31A$138.95 B44.38%
2018-12-31A$96.23 B14.38%
2017-12-31A$84.14 B-1.32%
2016-12-31A$85.26 B26.5%
2015-12-31A$67.40 B114.06%
2014-12-31A$31.48 B13.69%
2013-12-31A$27.69 B21.73%
2012-12-31A$22.75 B207.42%
2011-12-31A$7.40 B38.41%
2010-12-31A$5.34 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
A$175.03 B-15.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$118.50 B-42.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$137.87 B-33.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$121.88 B-41.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$56.12 B-72.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$16.65 B-91.94%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$92.76 B-55.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
A$103.66 B-49.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
A$1.91 B-99.08%๐Ÿ‡บ๐Ÿ‡ธ USA